financetom
Business
financetom
/
Business
/
CCI orders anti-trust investigation into Apple over App Store policies
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
CCI orders anti-trust investigation into Apple over App Store policies
Dec 31, 2021 10:53 AM

Indian competition watchdog Competition Commission of India (CCI) on Friday ordered a detailed anti-trust investigation into iPhone-maker Apple over its business practices regarding its App Store.

In a 20-page order, the watchdog said that Apple's App Store is the only channel for app developers to distribute their apps to iOS consumers, and that iOS is pre-installed on every iPhone and iPad.

"Further, third-party app stores are not allowed to be listed on Apple's App Store as the developer guidelines as well as agreement prohibits app developers from offering such services... these restrictions imposed by Apple forecloses the market for app stores for iOS for potential app distributors," the order said.

According to the CCI, this prima facie results in denial of market access for the potential app distributors/app store developers in violation of competition norms.

Apple had faced anti-trust investigations by the European Union as well as the Federal Trade Commission in the United States. While the EU opened its investigation only recently, the US probe is in progress.

(Edited by : Vijay Anand)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Revvity to Acquire ACD/Labs to Expand its Signals Software Capabilities
Revvity to Acquire ACD/Labs to Expand its Signals Software Capabilities
Nov 10, 2025
Acquisition deepens Revvity Signals’ presence in research informatics while furthering its ongoing expansion into development and manufacturing solutions WALTHAM, Mass.--(BUSINESS WIRE)-- Revvity, Inc. ( RVTY ) , today announced it has entered into a definitive agreement to acquire ACD/Labs, a global provider of scientific software solutions that support analytical characterization and molecular design across pharmaceutical and material sciences end...
ADC Therapeutics Q3 net income beats analyst expectations
ADC Therapeutics Q3 net income beats analyst expectations
Nov 10, 2025
Overview * ADC Therapeutics ( ADCT ) Q3 net income and income from operations beat analyst expectations * Net product revenues for Q3 2025 declined due to lower sales volume * Completed $60 mln PIPE financing to expand ZYNLONTA and strengthen balance sheet Outlook * ADC Therapeutics ( ADCT ) expects LOTIS-7 data by end of 2025 * Company anticipates...
Retail rally running out of steam after record streak, J.P. Morgan warns
Retail rally running out of steam after record streak, J.P. Morgan warns
Nov 10, 2025
(Reuters) -Retail investors are dialing back their risky bets after the longest bullish streak in recent years, J.P. Morgan analysts wrote in a note, marking a shift in sentiment that could sap momentum in high-flying U.S. stocks. The brokerage's readout from Friday showed a drop in bullish options bets, with call volumes slipping compared to puts, after roughly 140 days...
Cabaletta Bio reports smaller-than-expected Q3 loss
Cabaletta Bio reports smaller-than-expected Q3 loss
Nov 10, 2025
Overview * Company advancing rese-cel clinical trials with promising data for autoimmune diseases * Cabaletta expects cash reserves to fund operations into the second half of 2026 Outlook * Cabaletta plans BLA submission for rese-cel in 2027 * Company expects FDA alignment on cohort designs by end of 2025 * Cabaletta anticipates enrollment in registrational cohorts in 2026 Result Drivers...
Copyright 2023-2026 - www.financetom.com All Rights Reserved